During November 9-13, 2018, the 69thAnnual Meeting of American Association for the Study of Liver Diseases (AASLD) was held in San Francisco, a famous city on the west coast of America. A total of six physicians from the Infection Department of theFirst Affiliated Hospital of Xi’an Jiaotong Universityattended the meeting, and three studies were selected for poster demonstration.
The meeting focused on the latest researches in basic, clinical and transformational medicines, including HBV, HCV, ALD, NAFLD, hepatobiliary tumor, ACLF, liver transplantation, cholestatic disease, pediatric liver disease, liver toxicity, portal hypertension and hepatocyte biology. Two studies and one study of research groups led by Professor Zhao Yingren and Professor Lin Shumei respectively were selected for poster demonstration. What’s more, the following professors and some doctoral students and master students attended the annual meeting: Professor Liu Zhengwen, Professor Chen Tianyan, Physician Zhang Xi, doctoral students Tian Zhen and Yao Naijuan and master student An Xiaocui.
Doctor Tian demonstrated his latest research achievements by the poster titled “Association between Plasma Level of SOD and Survival of Patients with Acute-on-Chronic Liver Failure”, which revealed the role of oxidative stress in the pathogenesis of acute-on-chronic liver failure, and that the combination of serum SOD level with MELD score can effectively improve the accuracy of predicting the prognosis of patients with acute-on-chronic liver failure. Doctor Yao’s poster titled “Initiation of Antiviral Therapy of 24 Weeks of Gestation Is Recommended to Eliminate HBV Infection” showed that the safety of the medication for woman with hepatitis B who is pregnant for 24 weeks is the same as the one who is pregnant for 28 weeks, but the virus inhibition effect of the former is more noticeable. To better block mother-to-infant transmission of HBV, medication can be administered at 24 weeks of pregnancy. The poster titled “Vitamin D Is a Potential Predictor Related with Progression and Prognostic of Chronic Hepatitis B” jointly prepared by Doctor Zhang and Master An showed that the vitamin D level of patients with chronic hepatitis B is significantly lower than that of the normal population, and their lower vitamin D level is a predictor for disease progression and prognosis.
These three studies have fully demonstrated the progress and achievements made by the Infection Department in the research of liver diseases, and further enhanced its international influence in the field of scientific and technological research.
